The Technical Analyst
Select Language :
Aprea Therapeutics Inc [APRE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Aprea Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Aprea Therapeutics Inc is listed at the  Exchange

10.21% $6.69

America/New_York / 28 mar 2024 @ 16:00


Aprea Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 25.00 mill
EPS: 12.31
P/E: 0.540
Earnings Date: May 12, 2024
SharesOutstanding: 3.74 mill
Avg Daily Volume: 0.0376 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/a
Gr.Profitn/an/an/a
Ebit
Asset
Debtn/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0.540 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.09x
Company: PE 0.540 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$5.97
(-10.72%) $-0.717
Date: 2024-03-29
Expected Trading Range (DAY)

$ 6.00 - 7.38

( +/- 10.27%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-28 Hamill John P. Buy 3 365 Common Stock
2024-03-28 Hamill John P. Buy 13 460 Stock Options (Right to Buy)
2024-03-28 Gilad Oren Buy 6 725 Common Stock
2024-03-28 Gilad Oren Buy 26 900 Stock Options (Right to Buy)
2024-03-13 Hamill John P. Buy 1 010 Common Stock
INSIDER POWER
89.49
Last 96 transactions
Buy: 13 026 874 | Sell: 1 205 176

Forecast: 16:00 - $6.60

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $6.60
Forecast 2: 16:00 - $6.60
Forecast 3: 16:00 - $6.60
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $6.69 (10.21% )
Volume 0.0284 mill
Avg. Vol. 0.0376 mill
% of Avg. Vol 75.50 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Aprea Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Aprea Therapeutics Inc

RSI

Last 10 Buy & Sell Signals For APRE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Aprea Therapeutics Inc

APRE

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.

Last 10 Buy Signals

Date Signal @
YFIIUSDMar 29 - 07:30$609.96
PAXGUSDMar 29 - 07:302 210.17
XAUTUSDMar 29 - 07:19$2 232.78
POLYXUSDMar 29 - 07:190.529
VRXUSDMar 29 - 07:1862.71
TOMOUSDMar 29 - 07:13$1.061
POOLXUSDMar 29 - 07:095.22
COREUSDMar 29 - 07:086 994.98
PENDLEUSDMar 29 - 07:094.21
BFICUSDMar 29 - 07:079.89

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.